Growth-promoting effects of oxidized low density lipoprotein

Canadian Journal of Cardiology

Volumn 17, Issue 1, 2001, Pages 73-79

  Zettler, M E ^a   Pierce, G N ^a  

^a ST BONIFACE GENERAL HOSPITAL RESEARCH CENTRE   (Canada)

Author keywords

Atherosclerosis; Growth substances; Lipoproteins; Proteins; Smooth muscle

Indexed keywords

CELL CYCLE PROTEIN; COLONY STIMULATING FACTOR 1; CYCLIN A; CYCLIN B1; CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN E; CYCLINE; CYTOKINE; DNA; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; OXIDIZED LOW DENSITY LIPOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULOTROPIN;

ATHEROSCLEROSIS; CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; ENDOTHELIUM CELL; GENE EXPRESSION; HUMAN; INFLAMMATION; MITOGENESIS; NONHUMAN; PROTEIN INDUCTION; REVIEW; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

ANIMALS; ARTERIOSCLEROSIS; CELL DIVISION; CYTOKINES; ENZYME ACTIVATION; GROWTH SUBSTANCES; HUMANS; INFLAMMATION MEDIATORS; LIPOPROTEINS, LDL; OXIDATION-REDUCTION; SECOND MESSENGER SYSTEMS; TRANSCRIPTION FACTORS;

EID: 0035123844     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (70)

1. The pathogenesis of atherosclerosis: A perspective for the 1990s
2. Low density lipoprotein oxidation and its pathobiological significance
3. Contrary effects of lightly and strongly oxidized LDL with potent promotion of growth versus apoptosis on arterial smooth muscle cells, macrophages, and fibroblasts
4. Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells
5. Oxidized low density lipoprotein stimulates aortic smooth muscle cell proliferation
6. Vascular smooth muscle proliferation: Synergistic interaction between serotonin and low density lipoproteins
7. Proliferative and cytotoxic effects of mildly oxidized low-density lipoproteins on vascular smooth-muscle cells
8. A modification of apolipoprotein B accounts for most of the induction of macrophage growth by oxidized low density lipoprotein
9. Lysophosphatidylcholine plays an essential role in the mitogenic effect of oxidized low density lipoprotein on murine macrophages
10. Oxidized LDL can induce macrophage survival, DNA synthesis, and enhanced proliferative response to CSF-1 and GM-CSF
11. Induction of human endothelial cell growth by mildly oxidized low density lipoprotein
12. Rules to replicate by
13. Principles of CDK regulation
14. Protein kinases and protooncogenes: Biochemical regulators of the eukaryotic cell cycle
15. Ordering S phase and M phase in the cell cycle
16. Mitosis in transition
17. Copper and cell-oxidized low-density lipoprotein induces activator protein 1 in fibroblasts, endothelial and smooth muscle cells
18. Protective role of glutathione synthesis in response to oxidized low density lipoprotein in human vascular endothelial cells
19. Oxidized LDL activates STAT1 and STAT3 transcription factors: Possible involvement of reactive oxygen species
20. Oxidized low density lipoprotein induces activation of the transcription factor NF kappa B in fibroblasts, endothelial and smooth muscle cells
21. Dysregulation of monocytic nuclear factor-kappa B by oxidized low-density lipoprotein
22. Induction of monocyte binding to endothelial cells by MM-LDL: Role of lipoxygenase metabolites
23. Gamma-tocopherol decreases oxLDL-mediated activation of nuclear factor-kappaB and apoptosis in human coronary artery endothelial cells
24. Mildly oxidized low-density lipoproteins decrease early production of interleukin 2 and nuclear factor kappaB binding to DNA in activated T-lymphocytes
25. Oxidized LDL modulates activation of NFkappaB in mononuclear phagocytes by altering degradation of IkappaBs
26. Oxidized low density lipoprotein suppresses activation of NFkB in macrophages via a pertussis toxin-sensitive signaling mechanism
27. Autoantibody against oxidised LDL and progression of carotid atherosclerosis
28. Oxidized LDL-containing immune complexes induce Fc gamma receptor I-mediated mitogen-activated protein kinase activation in THP-1 macrophages
29. Involvement of the immune system in human atherogenesis: Current knowledge and unanswered questions
30. Synthesis of IL-1 alpha and beta by arterial cells in atherosclerosis
31. Production of TNF and IL-1 by macrophages from human atheromatous plaques
32. IL-6 gene transcripts are expressed in human atherosclerotic lesions
33. Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity
34. Components of the protein fraction of oxidized low density lipoprotein stimulate interleukin-1 alpha production by rabbit arterial macrophage-derived foam cells
35. Multiple lipid oxidation products in LDL induce interleukin-1b release from human blood mononuclear cells
36. Induction of murine macrophage growth by oxidized low density lipoprotein is mediated by granulocyte macrophage colony-stimulating factor
37. Oxidized LDL increases and interferon-gamma decreases expression of CD36 in human monocyte-derived macrophages
38. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase
39. Specific interaction of oxidized low-density lipoprotein with macrophage-derived foam cells isolated from rabbit atherosclerotic lesions
40. Expression of lectin-like oxidized low density lipoprotein receptor-1 in human and murine macrophages: Upregulated expression by TNF-alpha
41. Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein
42. Oxidized low density lipoprotein suppresses the expression of tumor necrosis factor-alpha mRNA in stimulated murine peritoneal macrophages
43. Inhibition of lipopolysaccharide-induced interleukin-1 beta mRNA expression in mouse macrophages by oxidized low density lipoprotein
44. Oxidized low-density lipoproteins affect natural killer cell activity by impairing cytoskeleton function and altering the cytokine network
45. Platelet-derived growth factor gene expression in human atherosclerotic plaques and normal artery wall
46. Induction of B-type receptor for platelet-derived growth factor in vascular inflammation: Possible implications for development of vascular proliferative lesions
47. The influence of oxidatively modified low density lipoproteins on expression of platelet-derived growth factor by human monocyte-derived macrophages
48. Lipoprotein-mediated inhibition of endothelial cell production of platelet-derived growth factor-like protein depends on free radical lipid peroxidation
49. Induction of macrophage VEGF in response to oxidized LDL and VEGF accumulation in human atherosclerotic lesions
50. Oxidized LDL mediates the release of fibroblast growth factor-1
51. Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells. Evidence for release of fibroblast growth factor-2
52. Apoptosis caused by oxidized LDL is manganese superoxide and p53 dependent
53. Role of sphingosine 1-phosphate in the mitogenesis induced by oxidized low density lipoprotein in smooth muscle cells via activation of sphingomyelinase, ceramidase, and sphingosine kinase
54. Sphingolipids in atherosclerosis and vascular biology
55. Calcium signalling and cell proliferation
56. Oxidation of low density lipoprotein enhances its potential to increase intracellular free calcium concentration in vascular smooth muscle cells
57. Chronic exposure of smooth muscle cells to minimally oxidized low density lipoprotein results in depressed IP3 receptor density and Ca2+ transients
58. Two intracellular signaling pathways for activation of protein kinase C are involved in oxidized low-density lipoprotein-induced macrophage growth
59. Cell-cycle calcium transients driven by cyclic changes in inositol triphosphate levels
60. Oxidized low density lipoproteins stimulate phosphoinositide turnover in cultured vascular smooth muscle cells
61. Activation of p38 mitogen-activated protein kinase by oxidized LDL in vascular smooth muscle cells: Mediation via pertussis toxin-sensitive G proteins and association with oxidized LDL-induced cytotoxicity
62. Oxidized LDL stimulates mitogen-activated protein kinases in smooth muscle cells and macrophages
63. Stimulation of mitogen activated protein kinase by LDL and oxLDL in human U-937 macrophage-like cells
64. Oxidized low density lipoprotein stimulates protein kinase C (PKC) activity and expression of PKC-isotypes via prostaglandin-H-synthase in P388D1 cells
65. Oxidized low-density lipoprotein stimulates protein kinase C (PKC) and induces expression of PKC-isotypes via prostaglandin-H-synthase in P388D1 macrophage-like cells
66. Activation of EGF receptor by oxidized LDL
67. Phosphatidylinositol 3-kinase is involved in the induction of macrophage growth by oxidized low density lipoprotein
68. Oxidized low density lipoprotein-mediated activation of phospholipase D in smooth muscle cells: A possible role in cell proliferation and atherogenesis
69. Stimulation of phospholipase D activity by oxidized LDL in mouse peritoneal macrophages
70. Oxidatively modified LDL contains phospholipids with platelet-activating factor-like activity and stimulates the growth of smooth muscle cells